Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        Dr Omar Elaskalani

        Senior Research Officer

        Senior Research Officer

        BSc, MSc, PhD

        Dr. Omar Elaskalani is a cancer researcher who studies the distinctive microenvironment of paediatric cancers. Omar and his team develop and apply innovative preclinical models and cutting-edge single-cell omics to uncover age-specific immune-targeted therapies to effectively treat children with cancer.

        Find Dr Elaskalani on ORCID.

        Email me LinkedIn
        • Projects

          Kids are not small adults, Identifying age-dependent drug targets in paediatric oncology

          Learn more

          Developing new immune based therapies for neuroblastoma

          Learn more
        • Education and Qualifications
          • PhD in Biomedical Sciences (Pancreatic cancer), 2019, Curtin University, Australia
          • MSc in Drug design (Development and evaluation of anticancer compounds), 2014, University of Salford, UK
          • Postgraduate Diploma (clinical pharmacy), 2010, Ain Shams University, Egypt
          • BSc in Pharmaceutical Sciences, 2008, Zagazig University, Egypt
        • Awards/Honours
          • Research Focus Area Collaboration Award, Telethon Kids Institute (2022)
          • IGNITE EMCR project grant, Telethon Kids Institute (2022)
          • Best oral presentation award at the annual scientific meeting of the Thrombosis and Haemostasis society of Australia and New Zealand (2019)
          • Science on the Swan conference-best poster award (2017)
          • The Annual Perth Combined Biological Sciences Meeting prize for the most outstanding student poster presentation (2016)
          • Health Sciences Faculty International Research Scholarship, Curtin University (2015)
          • Vice Chancellor's Excellence Scholarship, University of Salford, UK (2013)

        Cancer Immunology and Biology team

        Researchers within the Cancer Immunology and Biology group are working to develop safer immunotherapy and personalised medicine treatments across various deadly childhood cancers, including brain cancer, sarcoma, leukaemia, and neuroblastoma.

        View team